title: Meyerson's naevi induced by interferon alfa plus ribavirin combination therapy in hepatitis C infection.
authors.forename: A
authors.initials: A
authors.lastname: Conde-Taboada
authors.forename: C
authors.initials: C
authors.lastname: de la Torre
authors.forename: C
authors.initials: C
authors.lastname: Feal
authors.forename: E
authors.initials: E
authors.lastname: Mayo
authors.forename: B
authors.initials: B
authors.lastname: Gonzalez-Sixto
authors.forename: M J
authors.initials: MJ
authors.lastname: Cruces
mesh_terms: D000328:Adult; D000998:Antiviral Agents / Q000009:adverse effects*; D003875:Drug Eruptions / Q000209:etiology*; D004359:Drug Therapy, Combination; D019698:Hepatitis C, Chronic / Q000188:drug therapy*; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000009:adverse effects*; D008297:Male; D009506:Nevus / Q000139:chemically induced; D011994:Recombinant Proteins; D012254:Ribavirin / Q000009:adverse effects*; D012878:Skin Neoplasms / Q000139:chemically induced
chemical_list: D000998:Antiviral Agents; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins; D012254:Ribavirin